Skip to main content
TipRanks
Go Ultimate75% OFF

Delivra Health Brands (DHB) Stock Price & Analysis

99 Followers

DHB Stock Chart & Stats

CA$0.09-CA$0.00(-5.56%)
At close: 4:00 PM EST
C$0.075C$0.1C$0.125Aug 17Sep 1Sep 10Sep 29Oct 14Oct 26Nov 9
Day’s Range
CAD 0.08 - CAD 0.09
52-Week Range
CAD 0.07 - CAD 0.32
Previous Close
CAD 0.09
Volume
N/A
Average Volume (3M)
8,948
Market Cap
CAD 2.66M
Enterprise Value
CAD 3.92M
Total Cash (Recent Filing)
CAD 2.85M
Total Debt (Recent Filing)
CAD 2.41M
Price to Earnings (P/E)
―
Beta
1.99
Next Earnings
Nov 30, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Portfolio And Channel Diversification

A portfolio-based model spanning pain management, personal care, retail, contract manufacturing, and distribution gives Delivra multiple routes to market. This breadth can support brand development and reduce reliance on one product line or customer channel over the coming quarters.

Losses Improved Versus Historical Extremes

Although the latest results remain unprofitable, losses are materially below the extreme levels recorded in 2021–2022. That improvement indicates some longer-term operational recovery has occurred, providing a more stable base if management can restore revenue and margins.

Cash Burn Has Narrowed

Free cash flow remains negative, but the loss narrowed from 2025 and is substantially better than the 2021–2022 period. Reduced cash burn can preserve financial runway and improve self-funding potential if the company continues moving toward positive operating cash flow.

Bears Say

Sharp Revenue Contraction

A sharp annual revenue decline reverses the company’s prior growth pattern and weakens the scale supporting its brand portfolio. Unless demand and distribution recover, lower sales can limit operating leverage, reduce reinvestment capacity, and prolong the path to sustainable profitability.

Margin Compression And Renewed Losses

The combination of materially lower gross margin and renewed net losses indicates that recent revenue is producing less economic value. Persistent margin pressure would constrain the company’s ability to cover fixed costs, fund product development, and achieve durable earnings improvement.

Rising Leverage And Negative Cash Flow

Higher debt relative to a shrinking equity base reduces financial flexibility while negative operating and free cash flow weaken internal funding. If profitability does not stabilize, Delivra may have less capacity to absorb setbacks, invest in growth, or manage ongoing financial obligations.

Delivra Health Brands News

DHB FAQ

What was Delivra Health Brands’s price range in the past 12 months?
Delivra Health Brands lowest stock price was C$0.07 and its highest was C$0.32 in the past 12 months.
What is Delivra Health Brands’s market cap?
Delivra Health Brands’s market cap is C$2.66M.
When is Delivra Health Brands’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Delivra Health Brands’s earnings last quarter?
Delivra Health Brands released its earnings results on May 29, 2026. The company reported -C$0.03 earnings per share for the quarter.
Is Delivra Health Brands overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Delivra Health Brands pay dividends?
Delivra Health Brands does not currently pay dividends.
What is Delivra Health Brands’s EPS estimate?
Delivra Health Brands’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Delivra Health Brands have?
Delivra Health Brands has 31,261,782 shares outstanding.
What happened to Delivra Health Brands’s price movement after its last earnings report?
Delivra Health Brands reported an EPS of -C$0.03 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Delivra Health Brands?
Currently, no hedge funds are holding shares in TSE:DHB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology